SLC19A1 and acute lymphoblastic leukemia: Although low SLC19A1 and FPGS as well as high DHFR and TYMS expression levels have been correlated with poor patient MTX response [157,178,179,180,181], some important factors, such as genomic landscape, MTX dosage (high or low), and the subtype of ALL, should be taken into account.